- Neuromuscular blockade management in patients with COVID-19
-
Chaves-Cardona H, Hernandez-Torres V, Kiley S, Renew J
- KMID: 2520721
- Korean J Anesthesiol.
- 2021 Aug;74(4):285-292.
- doi: 10.4097/kja.21106
This narrative review evaluates the evidence for using neuromuscular blocking agents (NMBA) in patients being treated for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While large prospective randomized-controlled trials (RCTs)... -
- CITED
-
- Close
- SHARE
-
- Close
